Published in Eur J Biochem on May 01, 2004
Arginase: an emerging key player in the mammalian immune system. Br J Pharmacol (2009) 2.59
Gene expression in vivo shows that Helicobacter pylori colonizes an acidic niche on the gastric surface. Proc Natl Acad Sci U S A (2007) 1.42
Modulation of the arginase pathway in the context of microbial pathogenesis: a metabolic enzyme moonlighting as an immune modulator. PLoS Pathog (2010) 1.39
Replacing Mn(2+) with Co(2+) in human arginase i enhances cytotoxicity toward l-arginine auxotrophic cancer cell lines. ACS Chem Biol (2010) 1.19
In vitro and in vivo complementation of the Helicobacter pylori arginase mutant using an intergenic chromosomal site. Helicobacter (2006) 1.07
Characterization of Bacillus anthracis arginase: effects of pH, temperature, and cell viability on metal preference. BMC Biochem (2008) 0.99
Transcriptional profiling of gastric epithelial cells infected with wild type or arginase-deficient Helicobacter pylori. BMC Microbiol (2012) 0.95
H. pylori virulence factors: influence on immune system and pathology. Mediators Inflamm (2014) 0.88
Genetic microheterogeneity and phenotypic variation of Helicobacter pylori arginase in clinical isolates. BMC Microbiol (2007) 0.86
High-level expression of human arginase I in Pichia pastoris and its immobilization on chitosan to produce L-ornithine. BMC Biotechnol (2015) 0.85
Schistosoma mansoni arginase shares functional similarities with human orthologs but depends upon disulphide bridges for enzymatic activity. Int J Parasitol (2008) 0.82
Enzymatic Activity of Xyloglucan Xylosyltransferase 5. Plant Physiol (2016) 0.79
Characterization in Helicobacter pylori of a Nickel Transporter Essential for Colonization That Was Acquired during Evolution by Gastric Helicobacter Species. PLoS Pathog (2016) 0.77
Crystallization and preliminary crystallographic studies of Helicobacter pylori arginase. Acta Crystallogr Sect F Struct Biol Cryst Commun (2011) 0.77
Coagulase-negative Staphylococci favor conversion of arginine into ornithine despite a widespread genetic potential for nitric oxide synthase activity. Appl Environ Microbiol (2014) 0.77
Structure and function of non-native metal clusters in human arginase I. Biochemistry (2012) 0.77
Expression, purification and characterization of arginase from Helicobacter pylori in its apo form. PLoS One (2011) 0.76
Transition Metals and Virulence in Bacteria. Annu Rev Genet (2016) 0.76
The second-shell metal ligands of human arginase affect coordination of the nucleophile and substrate. Biochemistry (2010) 0.76
Helicobacter pylori arginase mutant colonizes arginase II knockout mice. World J Gastroenterol (2011) 0.75
Arginase of Helicobacter Gastric Pathogens Uses a Unique Set of Non-catalytic Residues for Catalysis. Biophys J (2017) 0.75
Construction of a highly efficient Bacillus subtilis 168 whole-cell biocatalyst and its application in the production of L-ornithine. J Ind Microbiol Biotechnol (2015) 0.75
Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res (2005) 6.66
Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses. Cancer Res (2004) 4.74
Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives. Immunol Rev (2008) 4.40
Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res (2009) 4.16
Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma. J Exp Med (2005) 3.80
L-arginine availability regulates T-lymphocyte cell-cycle progression. Blood (2006) 3.17
L-arginine consumption by macrophages modulates the expression of CD3 zeta chain in T lymphocytes. J Immunol (2003) 2.91
Regulation of T cell receptor CD3zeta chain expression by L-arginine. J Biol Chem (2002) 2.62
The complete genome sequence of the carcinogenic bacterium Helicobacter hepaticus. Proc Natl Acad Sci U S A (2003) 2.62
Chorioamnionitis and cerebral palsy: a meta-analysis. Obstet Gynecol (2010) 2.30
Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism. Cancer Res (2009) 1.99
The complete genome sequence and analysis of the epsilonproteobacterium Arcobacter butzleri. PLoS One (2007) 1.78
Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev (2006) 1.69
Decreased expression of CD3zeta and nuclear transcription factor kappa B in patients with pulmonary tuberculosis: potential mechanisms and reversibility with treatment. J Infect Dis (2006) 1.53
Crystal structure of human arginase I at 1.29-A resolution and exploration of inhibition in the immune response. Proc Natl Acad Sci U S A (2005) 1.46
L-Arginine modulates CD3zeta expression and T cell function in activated human T lymphocytes. Cell Immunol (2005) 1.45
Metabolism of L-arginine by myeloid-derived suppressor cells in cancer: mechanisms of T cell suppression and therapeutic perspectives. Immunol Invest (2012) 1.43
Sex hormones, hormonal interventions, and gastric cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev (2011) 1.41
Helicobacter pylori arginase inhibits T cell proliferation and reduces the expression of the TCR zeta-chain (CD3zeta). J Immunol (2004) 1.37
Campylobacter jejuni response to human mucin MUC2: modulation of colonization and pathogenicity determinants. J Med Microbiol (2008) 1.19
Pegylated arginase I: a potential therapeutic approach in T-ALL. Blood (2010) 1.17
T cell dysfunction in cancer: role of myeloid cells and tumor cells regulating amino acid availability and oxidative stress. Semin Cancer Biol (2005) 1.16
Ethnic differences in cytokine gene polymorphisms: potential implications for cancer development. Cancer Immunol Immunother (2007) 1.15
Gastric cancer risk in a Mexican population: role of Helicobacter pylori CagA positive infection and polymorphisms in interleukin-1 and -10 genes. Int J Cancer (2006) 1.12
Characterization of the genes rdxA and frxA involved in metronidazole resistance in Helicobacter pylori. Res Microbiol (2003) 1.11
Cytokine genetic polymorphisms and prostate cancer aggressiveness. Carcinogenesis (2009) 1.09
Roles of alpha and beta carbonic anhydrases of Helicobacter pylori in the urease-dependent response to acidity and in colonization of the murine gastric mucosa. Infect Immun (2007) 1.08
In vitro and in vivo complementation of the Helicobacter pylori arginase mutant using an intergenic chromosomal site. Helicobacter (2006) 1.07
Innovations and challenges in renal cell carcinoma: summary statement from the Second Cambridge Conference. Clin Cancer Res (2007) 1.07
L-arginine deprivation regulates cyclin D3 mRNA stability in human T cells by controlling HuR expression. J Immunol (2010) 1.06
Cannabinoid neuroimmune modulation of SIV disease. J Neuroimmune Pharmacol (2011) 1.04
Subpopulations of myeloid-derived suppressor cells impair T cell responses through independent nitric oxide-related pathways. Int J Cancer (2013) 1.04
Association of interleukin-1beta gene polymorphisms with precancerous gastric lesions in African Americans and Caucasians. Am J Gastroenterol (2006) 1.04
Helicobacter pylori AlpA and AlpB bind host laminin and influence gastric inflammation in gerbils. Infect Immun (2011) 1.03
The Helicobacter pylori flbA flagellar biosynthesis and regulatory gene is required for motility and virulence and modulates urease of H. pylori and Proteus mirabilis. J Med Microbiol (2002) 1.03
Interactions of cytokine gene polymorphisms in prostate cancer risk. Carcinogenesis (2008) 1.03
Cholesterol enhances Helicobacter pylori resistance to antibiotics and LL-37. Antimicrob Agents Chemother (2011) 1.02
Cerebrospinal fluid miRNA profile in HIV-encephalitis. J Cell Physiol (2013) 0.98
Citrulline can preserve proliferation and prevent the loss of CD3 zeta chain under conditions of low arginine. JPEN J Parenter Enteral Nutr (2004) 0.96
Cytokine polymorphisms and gastric cancer risk: an evolving view. Cancer Biol Ther (2007) 0.96
Transcriptional profiling of gastric epithelial cells infected with wild type or arginase-deficient Helicobacter pylori. BMC Microbiol (2012) 0.95
Helicobacter pylori thioredoxin is an arginase chaperone and guardian against oxidative and nitrosative stresses. J Biol Chem (2005) 0.94
Requirement for inducible nitric oxide synthase in chronic allergen exposure-induced pulmonary fibrosis but not inflammation. J Immunol (2010) 0.93
Antibiotic treatment decreases microbial burden associated with pseudomyxoma peritonei and affects β-catenin distribution. Clin Cancer Res (2013) 0.93
Modulation of gut-specific mechanisms by chronic δ(9)-tetrahydrocannabinol administration in male rhesus macaques infected with simian immunodeficiency virus: a systems biology analysis. AIDS Res Hum Retroviruses (2014) 0.92
Unique host iron utilization mechanisms of Helicobacter pylori revealed with iron-deficient chemically defined media. Infect Immun (2010) 0.91
A core microbiome associated with the peritoneal tumors of pseudomyxoma peritonei. Orphanet J Rare Dis (2013) 0.90
Mechanisms of tumor evasion. Cancer Treat Res (2005) 0.90
Role of the HefC efflux pump in Helicobacter pylori cholesterol-dependent resistance to ceragenins and bile salts. Infect Immun (2010) 0.90
CD14 gene promoter polymorphism in different clinical forms of tuberculosis. FEMS Immunol Med Microbiol (2004) 0.90
Adherence of Helicobacter pylori to abiotic surfaces is influenced by serum. Appl Environ Microbiol (2007) 0.89
Vitamin B6 is required for full motility and virulence in Helicobacter pylori. MBio (2010) 0.88
Is Helicobacter pylori a true microaerophile? Helicobacter (2006) 0.88
Identification of speckle-type POZ protein somatic mutations in African American prostate cancer. Asian J Androl (2014) 0.88
Oxygen requirement and tolerance of Campylobacter jejuni. Res Microbiol (2007) 0.88
Potential role of thiol:disulfide oxidoreductases in the pathogenesis of Helicobacter pylori. FEMS Immunol Med Microbiol (2007) 0.86
Genetic microheterogeneity and phenotypic variation of Helicobacter pylori arginase in clinical isolates. BMC Microbiol (2007) 0.86
Minocycline blocks asthma-associated inflammation in part by interfering with the T cell receptor-nuclear factor κB-GATA-3-IL-4 axis without a prominent effect on poly(ADP-ribose) polymerase. J Biol Chem (2012) 0.84
Mechanisms of tumor evasion from the immune response. Cancer Chemother Biol Response Modif (2003) 0.83
Low frequency of anticyclic citrullinated peptide antibodies in psoriatic arthritis but not in cutaneous psoriasis. J Clin Rheumatol (2006) 0.83
MiniReview: bioinformatic study of bile responses in Campylobacterales. FEMS Immunol Med Microbiol (2007) 0.82
Chronic binge alcohol administration accentuates expression of pro-fibrotic and inflammatory genes in the skeletal muscle of simian immunodeficiency virus-infected macaques. Alcohol Clin Exp Res (2014) 0.81
Phosphonate metabolism in Helicobacter pylori. Antonie Van Leeuwenhoek (2009) 0.81
Helicobacter spp. other than Helicobacter pylori. Helicobacter (2009) 0.80
Association of haplotypes of inflammation-related genes with gastric preneoplastic lesions in African Americans and Caucasians. Int J Cancer (2011) 0.80
Campylobacter jejuni response to ox-bile stress. FEMS Immunol Med Microbiol (2007) 0.80
A cohort study evaluating the implications of biology, weight status and socioeconomic level on global self-esteem competence among female African-American adolescents. J Natl Black Nurses Assoc (2013) 0.79
Association of the T allele of an intronic single nucleotide polymorphism in the colony stimulating factor 1 receptor with Crohn's disease: a case-control study. J Immune Based Ther Vaccines (2004) 0.78
Bioinformatic analysis of Helicobacter pylori XGPRTase: a potential therapeutic target. Helicobacter (2006) 0.78
IL1B polymorphisms and gastric cancer risk. Cancer Epidemiol Biomarkers Prev (2007) 0.78
Comparison of Helicobacter bilis-Associated Protein Expression in Huh7 Cells Harbouring HCV Replicon and in Replicon-Cured Cells. Int J Hepatol (2012) 0.78
Effects of human and porcine bile on the proteome of Helicobacter hepaticus. Proteome Sci (2012) 0.77
Response of Helicobacter hepaticus to bovine bile. J Proteome Res (2010) 0.77
Helicobacter pylori disulphide reductases: role in metronidazole reduction. FEMS Immunol Med Microbiol (2005) 0.77
Decreased expression of T-cell NF-kappaB p65 subunit in steroid-resistant nephrotic syndrome. Kidney Int (2004) 0.77
Wolinella succinogenes response to ox-bile stress. Antonie Van Leeuwenhoek (2007) 0.76
Hepatocellular carcinoma: prevalence and molecular pathogenesis of Helicobacter spp. Future Microbiol (2009) 0.76
Characterisation of Campylobacter jejuni genes potentially involved in phosphonate degradation. Gut Pathog (2009) 0.76
T cell CD3 receptor zeta (TCRzeta)-chain expression in children with idiopathic nephrotic syndrome. Pediatr Nephrol (2008) 0.76
Molecular responses of Campylobacter jejuni to cadmium stress. FEBS J (2008) 0.76
Insights into the molecular basis of the microaerophily of three Campylobacterales: a comparative study. Antonie Van Leeuwenhoek (2009) 0.76
Helicobacter pylori arginase mutant colonizes arginase II knockout mice. World J Gastroenterol (2011) 0.75
The antimicrobial agent C31G is effective for therapy for HSV-1 ocular keratitis in the rabbit eye model. Antiviral Res (2013) 0.75
Effects of Helicobacter hepaticus on the proteome of HEp-2 cells. Antonie Van Leeuwenhoek (2007) 0.75
Acetylation of androgen receptor by ARD1 promotes dissociation from HSP90 complex and prostate tumorigenesis. Oncotarget (2016) 0.75
Novel Helicobacter pylori therapeutic targets: the unusual suspects. Expert Rev Anti Infect Ther (2009) 0.75